Answers are grounded in this paper and cite their sources.
This observational study demonstrates improved survival in cholangiocarcinoma patients post liver transplantation, suggesting novel therapeutic approaches.
CT + SIRT 351 days : median timeframe from diagnosis to listing 114 days : median time from listing to LT 4,9 years : median follow-up after LT LT In a highly selected cohort of only six patients over 15 years, neoadjuvant SIRT combined with chemotherapy enabled favorable long-term outcomes after liver transplantation 5-year OS = 100% 5-year PFS = 44.4% 70 years Major comorbidities Early progression 2ndary resection n=6 n=19 n=19 In liver transplantated patients CT, chemotherapy; iCCA,
No takes yet. Share an insight, caveat, or question.
Giguet et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: